Bill Baruch, founder & president at Blue Line Capital, joins CNBC’s 'Halftime Report' to detail his latest portfolio buys.
A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface ...
We don’t know if, let alone when, Grey’s Anatomy will come to an end, but some fans are already imagining their ideal closing ...
In an increasingly acute surgeon shortage, artificial intelligence could help fill the gap, coaching medical students as they practice surgical techniques.
Investor's Business Daily on MSN
Stocks To Watch As Google Drives Rattled But Rebounding Market
As the Nasdaq holds tough after a five-day win streak, Google stock, Robinhood and others land on list of stocks to watch.
Briton Tom Aspinall said he has been diagnosed with Brown’s syndrome in both eyes and is not cleared to fight after an ...
A framework for evaluating clinical solutions in resource-constrained environments More than 50% of all procedures are now performed outside traditional hospital settings1, with ambulatory surgery ...
Federal payment updates, insurer reimbursement cuts and a wave of acquisitions are reshaping the ASC landscape heading into 2026. Here are 10 major policy moves and market developments from 2025: CMS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback